Wanjun Yu

1.9k total citations
68 papers, 1.5k citations indexed

About

Wanjun Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wanjun Yu has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Cancer Research and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wanjun Yu's work include MicroRNA in disease regulation (17 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (12 papers). Wanjun Yu is often cited by papers focused on MicroRNA in disease regulation (17 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (12 papers). Wanjun Yu collaborates with scholars based in China, United States and Japan. Wanjun Yu's co-authors include Jipeng Li, Yiping Wang, Yulan Song, Huaying Wang, Jun Chen, Jian‐Ping Luo, Fun Sun Chu, Yi‐Ping Wang, Shanfeng Li and Mingwei Jin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Journal of Agricultural and Food Chemistry.

In The Last Decade

Wanjun Yu

62 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanjun Yu China 20 979 839 227 134 113 68 1.5k
Qixing Mao China 21 1.1k 1.1× 640 0.8× 347 1.5× 122 0.9× 314 2.8× 55 1.6k
Xujun He China 23 843 0.9× 539 0.6× 176 0.8× 177 1.3× 254 2.2× 60 1.3k
Paweł Krawczyk Poland 24 781 0.8× 483 0.6× 633 2.8× 200 1.5× 663 5.9× 168 1.8k
Hongchun Liu China 22 516 0.5× 232 0.3× 128 0.6× 132 1.0× 161 1.4× 56 1.0k
Ismael Riquelme Chile 21 940 1.0× 709 0.8× 182 0.8× 98 0.7× 271 2.4× 48 1.5k
Ye Wang China 18 740 0.8× 205 0.2× 98 0.4× 97 0.7× 169 1.5× 58 1.1k
Saeed Daneshmandi Iran 21 372 0.4× 231 0.3× 83 0.4× 412 3.1× 259 2.3× 58 1.1k
Xuemei Jiang China 19 435 0.4× 224 0.3× 144 0.6× 140 1.0× 87 0.8× 66 1.0k
Nupur K. Das United States 17 722 0.7× 356 0.4× 293 1.3× 120 0.9× 164 1.5× 31 1.5k

Countries citing papers authored by Wanjun Yu

Since Specialization
Citations

This map shows the geographic impact of Wanjun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanjun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanjun Yu more than expected).

Fields of papers citing papers by Wanjun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanjun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanjun Yu. The network helps show where Wanjun Yu may publish in the future.

Co-authorship network of co-authors of Wanjun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanjun Yu. A scholar is included among the top collaborators of Wanjun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanjun Yu. Wanjun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuning, et al.. (2025). Structure and luminescence of Gd3Ga3MgSiO12:Cr3+ garnet phosphor with highly efficient broadband near-infrared emitting toward pc-LED application. Journal of Alloys and Compounds. 1040. 183627–183627. 2 indexed citations
3.
Xing, Jing, Jia Chen, Liping Chen, et al.. (2024). DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma. Journal of Experimental & Clinical Cancer Research. 43(1). 3–3. 13 indexed citations
5.
Ma, Jin, Cong Wang, Tieying Yin, et al.. (2023). Preparation and in Vitro Property Research of Cholic Acid Nanoparticles with Dual Functions of Hemostasis and Antibacterial. Iranian journal of pharmaceutical research. In Press(In Press). e135437–e135437. 1 indexed citations
6.
Wu, Lei‐Lei, Lihong Qiu, Xiaolu Chen, et al.. (2023). Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort. Respiratory Research. 24(1). 168–168. 3 indexed citations
8.
Chen, Liping, et al.. (2023). The Circular RNA circFOXK2 Enhances the Tumorigenesis of Non-Small Cell Lung Cancer Through the miR-149-3p/IL-6 Axis. Biochemical Genetics. 62(1). 95–111. 5 indexed citations
9.
Xing, Jing, et al.. (2023). A multidimensional pan‐cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma. The FASEB Journal. 37(4). e22849–e22849. 9 indexed citations
10.
Wang, Yiping, et al.. (2022). Decreased Incidence of Influenza During the COVID-19 Pandemic. SHILAP Revista de lepidopterología. 15 indexed citations
11.
Wang, Mei, Zheng Gong, Xinxin Zhao, et al.. (2020). Circular Rnas Emerge As Important Regulators with Great Potential for Clinical Application in Gastric Cancer. Biomarkers in Medicine. 15(1). 69–82. 1 indexed citations
12.
Xu, Tao, et al.. (2019). Endobronchial Ultrasound-Guided Iodine-125 Radioactive Seed Implantation as a Novel Therapy for Mediastinal Tumors. Cancer Biotherapy and Radiopharmaceuticals. 34(9). 547–550. 4 indexed citations
13.
Luo, Yun, Xiaojun Song, Julian Ye, et al.. (2018). Evaluation of an UltraFast LabChip V280 assay for detection of toxigenic Clostridium difficile. Diagnostic Microbiology and Infectious Disease. 92(4). 279–283. 3 indexed citations
14.
Wang, Huaying, et al.. (2018). NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease. Inflammation. 41(4). 1321–1333. 64 indexed citations
15.
Li, Jipeng, Ying Chen, Mingwei Jin, et al.. (2017). MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1. Oncology Letters. 13(3). 1451–1455. 15 indexed citations
16.
Li, Jipeng, Shanfeng Li, Jian‐Hua Wang, et al.. (2016). miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1. Tumor Biology. 37(10). 13287–13294. 45 indexed citations
18.
Li, Jipeng, Yulan Song, Yiping Wang, Jian‐Ping Luo, & Wanjun Yu. (2013). MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. Molecular and Cellular Biochemistry. 380(1-2). 277–282. 84 indexed citations
19.
Wang, Huaying, et al.. (2012). Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure. International Immunopharmacology. 14(4). 504–512. 59 indexed citations
20.
Dorner, Joe W., В. С. Соболев, Wanjun Yu, & Fun Sun Chu. (2003). Immunochemical Method for Cyclopiazonic Acid. Humana Press eBooks. 157. 71–80. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026